Insider Transactions in Q3 2021 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2021
|
Giovanni Caforio Executive Chair of the Board |
SELL
Open market or private sale
|
Direct |
25,000
-4.91%
|
$1,500,000
$60.64 P/Share
|
|
Aug 12
2021
|
David V Elkins EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
99,691
-39.6%
|
$6,579,606
$66.94 P/Share
|
|
Aug 12
2021
|
David V Elkins EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
70,000
+14.13%
|
$3,360,000
$48.49 P/Share
|
|
Aug 03
2021
|
Ann Powell EVP, Chief Human Resources |
SELL
Open market or private sale
|
Direct |
23,280
-32.84%
|
$1,583,040
$68.57 P/Share
|
|
Aug 02
2021
|
Giovanni Caforio Executive Chair of the Board |
SELL
Open market or private sale
|
Direct |
20,000
-3.78%
|
$1,360,000
$68.58 P/Share
|
|
Aug 01
2021
|
David V Elkins EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,736
-17.79%
|
$1,590,312
$67.87 P/Share
|
|
Aug 01
2021
|
David V Elkins EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
46,403
+25.8%
|
-
|
|
Jul 30
2021
|
Paul Von Autenried EVP, Chief Information Officer |
BUY
Bona fide gift
|
Indirect |
114,670
+50.0%
|
-
|
|
Jul 30
2021
|
Paul Von Autenried EVP, Chief Information Officer |
SELL
Bona fide gift
|
Direct |
114,670
-100.0%
|
-
|
|
Jul 30
2021
|
Paul Von Autenried EVP, Chief Information Officer |
SELL
Open market or private sale
|
Direct |
25,000
-17.9%
|
$1,700,000
$68.06 P/Share
|
|
Jul 30
2021
|
Rupert Vessey EVP & President, Research |
SELL
Open market or private sale
|
Direct |
158,393
-53.79%
|
$10,770,724
$68.05 P/Share
|
|
Jul 30
2021
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
150,967
+8.96%
|
$8,605,119
$57.02 P/Share
|
|
Jul 30
2021
|
Sandra Leung EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
29,390
-7.96%
|
$1,998,520
$68.04 P/Share
|
|
Jul 30
2021
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
SELL
Open market or private sale
|
Direct |
2,466
-15.18%
|
$165,222
$67.9 P/Share
|
|
Jul 01
2021
|
Karen Murphy Santiago SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
547
-3.64%
|
$36,102
$66.56 P/Share
|
|
Jul 01
2021
|
Karen Murphy Santiago SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,069
+6.63%
|
-
|
|
Jul 01
2021
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,786
-28.94%
|
$315,876
$66.56 P/Share
|
|
Jul 01
2021
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
9,356
+36.13%
|
-
|